HI
OLMA icon

Harbour Investments’s Olema Pharmaceuticals OLMA Stock Holding History

Harbour Investments’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$162 Buy
+10
New +$223 ﹤0.01% 4467

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Harbour Investments's OLMA Position: Q1 2026 in Review

Harbour Investments opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 10 shares worth $162. The stake represents ﹤0.01% of the portfolio and ranks #4467 among its holdings.

195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Harbour Investments held 10 shares of Olema Pharmaceuticals worth $162 as of Q1 2026.
  • Olema Pharmaceuticals was a new Harbour Investments position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4467 holding.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.